Bruker Corp. (NASDAQ:BRKR)

CAPS Rating: 3 out of 5

The Company designs, manufactures, services and markets analytical and life science systems and associated products to address the needs of its customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research.

Recs

0
Player Avatar pennysplants (99.55) Submitted: 12/20/2007 2:34:39 PM : Outperform Start Price: $9.02 BRKR Score: +73.34

Thank goodness I saw the "light" before closing out this position.

BRKR is consolidating *ITSELF*. Buying subsidiaries. Will be highly ACCRETIVE to earnings almost immediately.

In a sector I love. High insider ownership. Have a few lingering questions about management. Watch closely.

Featured Broker Partners


Advertisement